Kishor Bhatia
Patrimonio netto: - $ in data 31/08/2026
Patrimonio netto: - $ in data 31/08/2026
Kishor G.
Bhatia currently works at Lantern Pharma, Inc., as Chief Scientific Officer from 2019.
Dr. Bhatia also formerly worked at National Cancer Institute, as Director-AIDS Malignancy Program from 2007 to 2016 and Georgetown University, as Research Assistant Professor from 1985 to 1989.
Dr. Bhatia received his doctorate degree from the University of Mumbai and undergraduate degree from the University of Pune.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LANTERN PHARMA, INC. -.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LANTERN PHARMA INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2019 |
| Società | Posizione | Fine |
|---|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | 01/07/2016 |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1989 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Pune
University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale